291 related articles for article (PubMed ID: 32104222)
1. Interleukin-35 reduces inflammation in acute lung injury through inhibiting TLR4/NF-κB signaling pathways.
Pan W; Xu X; Wang Y; Song X
Exp Ther Med; 2020 Mar; 19(3):1695-1700. PubMed ID: 32104222
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-182-5p inhibits inflammation in LPS-treated RAW264.7 cells by mediating the TLR4/NF-κB signaling pathway.
Zhu M; Li Y; Sun K
Int J Clin Exp Pathol; 2018; 11(12):5725-5734. PubMed ID: 31949658
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine mitigates lipopolysaccharide-induced acute lung injury by modulating heat shock protein A12B to inhibit the toll-like receptor 4/nuclear factor-kappa B signaling pathway.
Wu W; He Y; Lin D; Zhang G; Zhang X; Zhang N; Xie T; Wei H
Chem Biol Interact; 2024 Jun; 398():111112. PubMed ID: 38901789
[TBL] [Abstract][Full Text] [Related]
6. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
7.
Liu TY; Zhao LL; Chen SB; Hou BC; Huang J; Hong X; Qing L; Fang Y; Tao Z
Exp Ther Med; 2020 Oct; 20(4):3733-3739. PubMed ID: 32855724
[TBL] [Abstract][Full Text] [Related]
8. [Effects of trichostatin A on the expressions of inflammatory cytokines and toll-like receptor 4 and the acetylation of nuclear factor-κB induced by lipopolysaccharide in macrophage].
Hu XL; Zhang X; Li Q; Qiu SF; Mei RH
Sheng Li Xue Bao; 2012 Dec; 64(6):651-6. PubMed ID: 23258328
[TBL] [Abstract][Full Text] [Related]
9. Salidroside Protects Lipopolysaccharide-Induced Acute Lung Injury in Mice.
Lu R; Wu Y; Guo H; Huang X
Dose Response; 2016; 14(4):1559325816678492. PubMed ID: 27928219
[TBL] [Abstract][Full Text] [Related]
10. miR-27a protects against acute lung injury in LPS-treated mice by inhibiting NF-κB-mediated inflammatory response.
Li W; Qiu X; Liu J; Han Y; Wei D; Ji G; Jiang H
Int J Clin Exp Pathol; 2018; 11(6):2980-2989. PubMed ID: 31938423
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-145-5p alleviated LPS-induced acute lung injury.
Yu YL; Yu G; Ding ZY; Li SJ; Fang QZ
J Biol Regul Homeost Agents; 2019; 33(4):1063-1072. PubMed ID: 31353880
[TBL] [Abstract][Full Text] [Related]
12. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
[TBL] [Abstract][Full Text] [Related]
13. Sodium Butyrate Inhibits the Inflammation of Lipopolysaccharide-Induced Acute Lung Injury in Mice by Regulating the Toll-Like Receptor 4/Nuclear Factor κB Signaling Pathway.
Liu J; Chang G; Huang J; Wang Y; Ma N; Roy AC; Shen X
J Agric Food Chem; 2019 Feb; 67(6):1674-1682. PubMed ID: 30661349
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
15. LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.
Li C; Yang D; Cao X; Wang F; Jiang H; Guo H; Du L; Guo Q; Yin X
Biochem Pharmacol; 2016 Aug; 113():57-69. PubMed ID: 27206337
[TBL] [Abstract][Full Text] [Related]
16. [Gallic acid inhibits inflammatory response of RAW264.7 macrophages by blocking the activation of TLR4/NF-κB induced by LPS].
Huang L; Hou L; Xue H; Wang C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1610-1614. PubMed ID: 27916090
[TBL] [Abstract][Full Text] [Related]
17. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
18. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
[TBL] [Abstract][Full Text] [Related]
19. Magnoflorine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Suppressing NF-κB and MAPK Activation.
Guo S; Jiang K; Wu H; Yang C; Yang Y; Yang J; Zhao G; Deng G
Front Pharmacol; 2018; 9():982. PubMed ID: 30214410
[TBL] [Abstract][Full Text] [Related]
20. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
